MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krasowski, M. D.
Right arrow Articles by Harrison, N. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krasowski, M. D.
Right arrow Articles by Harrison, N. L.

Vol. 53, Issue 3, 530-538, March 1998

Propofol and Other Intravenous Anesthetics Have Sites of Action on the gamma -Aminobutyric Acid Type A Receptor Distinct from That for Isoflurane

Matthew D. Krasowski, Vladimir V. Koltchine, Caroline E. Rick, Qing Ye, Suzanne E. Finn, and Neil L. Harrison

Departments of Anesthesia and Critical Care (C.E.R., Q.Y., S.E.F., N.L.H.) and Pharmacological and Physiological Sciences (V.V.K., N.L.H.), and Committee on Neurobiology (M.D.K.), University of Chicago, Chicago, Illinois 60637

Both volatile and intravenous general anesthetics allosterically enhance gamma -aminobutyric acid (GABA)-evoked chloride currents at the GABA type A (GABAA) receptor. Recent work has revealed that two specific amino acid residues within transmembrane domain (TM)2 and TM3 are necessary for positive modulation of GABAA and glycine receptors by the volatile anesthetic enflurane. We now report that mutation of these residues within either GABAA alpha 2 (S270 or A291) or beta 1 (S265 or M286) subunits resulted in receptors that retain normal or near-normal gating by GABA but are insensitive to clinically relevant concentrations of another inhaled anesthetic, isoflurane. To determine whether receptor modulation by intravenous general anesthetics also was affected by these point mutations, we examined the effects of propofol, etomidate, the barbiturate methohexital, and the steroid alphaxalone on wild-type and mutant GABAA receptors expressed in human embryonic kidney 293 cells. In most cases, these mutations had little or no effect on the actions of these intravenous anesthetics. However, a point mutation in the beta 1 subunit (M286W) abolished potentiation of GABA by propofol but did not alter direct activation of the receptor by high concentrations of propofol. These data indicate that the receptor structural requirements for positive modulation by volatile and intravenous general anesthetics may be quite distinct.


Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Saras, G. Gisselmann, A. K. Vogt-Eisele, K. S. Erlkamp, O. Kletke, H. Pusch, and H. Hatt
Histamine Action on Vertebrate GABAA Receptors: DIRECT CHANNEL GATING AND POTENTIATION OF GABA RESPONSES
J. Biol. Chem., April 18, 2008; 283(16): 10470 - 10475.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K.-Y. Li, C. Xiao, M. Xiong, E. Delphin, and J.-H. Ye
Nanomolar Propofol Stimulates Glutamate Transmission to Dopamine Neurons: A Possible Mechanism of Abuse Potential?
J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 165 - 174.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
X.-Q. Hu and R. W. Peoples
Arginine 246 of the Pretransmembrane Domain 1 Region Alters 2,2,2-Trichloroethanol Action in the 5-Hydroxytryptamine3A Receptor
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1011 - 1018.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. Jia, M. Yue, D. Chandra, G. E. Homanics, P. A. Goldstein, and N. L. Harrison
Isoflurane Is a Potent Modulator of Extrasynaptic GABAA Receptors in the Thalamus
J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1127 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Barann, I. Linden, S. Witten, and B. W. Urban
Molecular Actions of Propofol on Human 5-HT3A Receptors: Enhancement as Well as Inhibition by Closely Related Phenol Derivatives
Anesth. Analg., March 1, 2008; 106(3): 846 - 857.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Zeller, M. Arras, R. Jurd, and U. Rudolph
Identification of a Molecular Target Mediating the General Anesthetic Actions of Pentobarbital
Mol. Pharmacol., March 1, 2007; 71(3): 852 - 859.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G.-D. Li, D. C. Chiara, G. W. Sawyer, S. S. Husain, R. W. Olsen, and J. B. Cohen
Identification of a GABAA Receptor Anesthetic Binding Site at Subunit Interfaces by Photolabeling with an Etomidate Analog.
J. Neurosci., November 8, 2006; 26(45): 11599 - 11605.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
Y. Sato, N. Seo, and E. Kobayashi
Ethanol-Induced Hypnotic Tolerance Is Absent in N-Methyl-d-Aspartate Receptor {varepsilon}1 Subunit Knockout Mice.
Anesth. Analg., July 1, 2006; 103(1): 117 - 120.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
J.-H. Sou, M.-H. Chan, and H.-H. Chen
Ketamine, but not propofol, anaesthesia is regulated by metabotropic glutamate 5 receptors
Br. J. Anaesth., May 1, 2006; 96(5): 597 - 601.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
V. Erden, Z. Yangin, K. Erkalp, H. Delatioglu, F. Bahceci, and A. Seyhan
Increased Progesterone Production During the Luteal Phase of Menstruation May Decrease Anesthetic Requirement
Anesth. Analg., October 1, 2005; 101(4): 1007 - 1011.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. L Fisher
The {alpha}1 and {alpha}6 subunit subtypes of the mammalian GABAA receptor confer distinct channel gating kinetics
J. Physiol., December 1, 2004; 561(2): 433 - 448.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
V. B. Caraiscos, J. G. Newell, K. E. You-Ten, E. M. Elliott, T. W. Rosahl, K. A. Wafford, J. F. MacDonald, and B. A. Orser
Selective Enhancement of Tonic GABAergic Inhibition in Murine Hippocampal Neurons by Low Concentrations of the Volatile Anesthetic Isoflurane
J. Neurosci., September 29, 2004; 24(39): 8454 - 8458.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. A. Lobo, M. P. Mascia, J. R. Trudell, and R. A. Harris
Channel Gating of the Glycine Receptor Changes Accessibility to Residues Implicated in Receptor Potentiation by Alcohols and Anesthetics
J. Biol. Chem., August 6, 2004; 279(32): 33919 - 33927.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. Ahrens, G. Haeseler, M. Leuwer, B. Mohammadi, K. Krampfl, R. Dengler, and J. Bufler
2,6 Di-tert-butylphenol, a Nonanesthetic Propofol Analog, Modulates {alpha}1{beta} Glycine Receptor Function in a Manner Distinct from Propofol
Anesth. Analg., July 1, 2004; 99(1): 91 - 96.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Miko, E. Werby, H. Sun, J. Healey, and L. Zhang
A TM2 Residue in the {beta}1 Subunit Determines Spontaneous Opening of Homomeric and Heteromeric {gamma}-Aminobutyric Acid-gated Ion Channels
J. Biol. Chem., May 28, 2004; 279(22): 22833 - 22840.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Rusch, H. Zhong, and S. A. Forman
Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation
J. Biol. Chem., May 14, 2004; 279(20): 20982 - 20992.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. B. Gonzales, C. L. Bell-Horner, M. A. M. de la Cruz, J. A. Ferrendelli, D. F. Covey, and G. H. Dillon
Enantioselectivity of {alpha}-Benzyl-{alpha}-methyl-{gamma}-butyrolactone-Mediated Modulation of Anticonvulsant Activity and GABAA Receptor Function
J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 677 - 683.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Bali and M. H. Akabas
Defining the Propofol Binding Site Location on the GABAA Receptor
Mol. Pharmacol., January 1, 2004; 65(1): 68 - 76.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-s. S. Chang, R. Olcese, and R. W. Olsen
A Single M1 Residue in the {beta}2 Subunit Alters Channel Gating of GABAA Receptor in Anesthetic Modulation and Direct Activation
J. Biol. Chem., October 31, 2003; 278(44): 42821 - 42828.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
R. Flaishon, A. A. Weinbroum, L. Veenman, S. Leschiner, V. Rudick, and M. Gavish
Flumazenil Attenuates Development of Tolerance to Diazepam After Chronic Treatment of Mice with Either Isoflurane or Diazepam
Anesth. Analg., October 1, 2003; 97(4): 1046 - 1052.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
N. L. Harrison
Knockin' on the Door of General Anesthetic Mechanisms: But Will U.S. Researchers Be Shut Out?
Anesth. Analg., September 1, 2003; 97(3): 616 - 618.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Darbandi-Tonkabon, W. R. Hastings, C.-M. Zeng, G. Akk, B. D. Manion, J. R. Bracamontes, J. H. Steinbach, S. J. Mennerick, D. F. Covey, and A. S. Evers
Photoaffinity Labeling with a Neuroactive Steroid Analogue. 6-AZI-PREGNANOLONE LABELS VOLTAGE-DEPENDENT ANION CHANNEL-1 IN RAT BRAIN
J. Biol. Chem., April 4, 2003; 278(15): 13196 - 13206.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Kitamura, W. Marszalec, J. Z. Yeh, and T. Narahashi
Effects of Halothane and Propofol on Excitatory and Inhibitory Synaptic Transmission in Rat Cortical Neurons
J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 162 - 171.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. Pain, S. Gobaille, C. Schleef, D. Aunis, and P. Oberling
In Vivo Dopamine Measurements in the Nucleus Accumbens After Nonanesthetic and Anesthetic Doses of Propofol in Rats
Anesth. Analg., October 1, 2002; 95(4): 915 - 919.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. B. Williams and M. H. Akabas
Structural Evidence that Propofol Stabilizes Different GABAA Receptor States at Potentiating and Activating Concentrations
J. Neurosci., September 1, 2002; 22(17): 7417 - 7424.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
K. W. Miller
The nature of sites of general anaesthetic action
Br. J. Anaesth., July 1, 2002; 89(1): 17 - 31.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D. Burke and D. J. Henderson
Chirality: a blueprint for the future
Br. J. Anaesth., April 1, 2002; 88(4): 563 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P J Hutchinson, M T O'Connell, P G Al-Rawi, C R Kett-White, A K Gupta, L B Maskell, J D Pickard, and P J Kirkpatrick
Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids
J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 99 - 105.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
D.M. Menon
Editorial I: Mapping the anatomy of unconsciousness--imaging anaesthetic action in the brain
Br. J. Anaesth., May 1, 2001; 86(5): 607 - 617.
[Full Text] [PDF]


Home page
Br J AnaesthHome page
M. T. Alkire and R. J. Haier
Correlating in vivo anaesthetic effects with ex vivo receptor density data supports a GABAergic mechanism of action for propofol, but not for isoflurane{{dagger}} {{ddagger}}
Br. J. Anaesth., May 1, 2001; 86(5): 618 - 626.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. D. Krasowski, A. Jenkins, P. Flood, A. Y. Kung, A. J. Hopfinger, and N. L. Harrison
General Anesthetic Potencies of a Series of Propofol Analogs Correlate with Potency for Potentiation of {gamma}-Aminobutyric Acid (GABA) Current at the GABAA Receptor but Not with Lipid Solubility
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 338 - 351.
[Abstract] [Full Text]


Home page
Anesth. Analg.Home page
G. Hapfelmeier, W. Zieglgansberger, R. Haseneder, H. Schneck, and E. Kochs
Nitrous Oxide and Xenon Increase the Efficacy of GABA at Recombinant Mammalian GABAA Receptors
Anesth. Analg., December 1, 2000; 91(6): 1542 - 1549.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. X. Carlson, A. C. Engblom, U. Kristiansen, A. Schousboe, and R. W. Olsen
A Single Glycine Residue at the Entrance to the First Membrane-Spanning Domain of the gamma -Aminobutyric Acid Type A Receptor beta 2 Subunit Affects Allosteric Sensitivity to GABA and Anesthetics
Mol. Pharmacol., March 1, 2000; 57(3): 474 - 484.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
V. V. Koltchine, S. E. Finn, A. Jenkins, N. Nikolaeva, A. Lin, and N. L. Harrison
Agonist Gating and Isoflurane Potentiation in the Human gamma -Aminobutyric Acid Type A Receptor Determined by the Volume of a Second Transmembrane Domain Residue
Mol. Pharmacol., November 1, 1999; 56(5): 1087 - 1093.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Yamakura, S. J. Mihic, and R. A. Harris
Amino Acid Volume and Hydropathy of a Transmembrane Site Determine Glycine and Anesthetic Sensitivity of Glycine Receptors
J. Biol. Chem., August 13, 1999; 274(33): 23006 - 23012.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. Ueno, J. R. Trudell, E. I Eger II, and R. A. Harris
Actions of Fluorinated Alkanols on GABAA Receptors: Relevance to Theories of Narcosis
Anesth. Analg., April 1, 1999; 88(4): 877 - 877.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. J. Beckstead, R. Phelan, and S. J. Mihic
Antagonism of Inhalant and Volatile Anesthetic Enhancement of Glycine Receptor Function
J. Biol. Chem., June 29, 2001; 276(27): 24959 - 24964.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Jenkins, E. P. Greenblatt, H. J. Faulkner, E. Bertaccini, A. Light, A. Lin, A. Andreasen, A. Viner, J. R. Trudell, and N. L. Harrison
Evidence for a Common Binding Cavity for Three General Anesthetics within the GABAA Receptor
J. Neurosci., March 15, 2001; 21(6): RC136 - RC136.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics